Epo-derived peptide agonists

Name of License: Epo-derived peptide agonists

Laboratory:

On: Feb 03, 2021

Summary:

Epo-derived peptide has neuro-protective activity

Tech Name: Epo-derived Peptide Agonists

Action: Intent to license exclusively

Dates: February 3, 2021 through February 19, 2021

Address: Department of Veterans Affairs Technology Transfer Program (RD14TT) Office of Research and Development 810 Vermont Avenue, NW. Washington, DC 20420

For Further Information Contact:

David Marks ([email protected])

Supplementary Information:

Belum Therapeutics requested exclusive license